Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

TRH test in patients with diabetes mellitus type 1 and/or autoimmune thyroiditis. Changes in the pituitary-thyroid axis, reverse T3, prolactin and growth hormone levels

E. Orlická, K. Vondra, M. Hill, J. Skibová, I. Sterzl, V. Zamrazil

. 2008 ; 57 (Suppl 1) : S109-S117.
. 2008 ; 57 (Suppl 1) : S109-S117.

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc13034117

The response of the pituitary- thyroid axis, reverse triiodothyronine (rT3), prolactin, and growth hormone (GH) levels following TRH stimulus (Relefact TRH 200 microg 2 amp. i.v.) was examined in patients with autoimmune diabetes type 1 (DM1, n=30), with autoimmune thyroiditis (AT, n=25), and with concurrent DM1 and AT (n=22) to evaluate the influence of DM1 and AT of autoimmune pathogenesis on the above-mentioned hormonal parameters. Statistical analysis (ANOVA) showed that: a) the response of TSH did not differ from control groups (C); b) free triiodothyronine (fT3), free thyroxine (fT4) and their ratio in DM1, DM1+AT and C rose in 120 and 180 min, while a similar increase was not seen in AT (p<0.000001); c) rT3 was not present in any group, with rT3 levels higher in AT (p<0.00002) and lower in DM1 (p<0.02); d) the response of GH had a paradoxical character in some patients in all groups, most often in DM1 (52 %, DM1 vs C, p <0.01). The characteristic response difference was not in the peak GH level, but the delayed return to basal levels in DM1 (p<0.0001) and an abrupt one in AT (p<0.0001). The major findings in DM1 were the differences in GH response, while significant impairment of pituitary-thyroid axis and PRL response to TRH was absent. AT was associated with impairment of TRH stimulated fT3, fT4, fT3/fT4 response and changes in rT3 levels, in spite of preserved TRH-stimulated TSH secretion. GH response in AT patients was also altered.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc13034117
003      
CZ-PrNML
005      
20151006120452.0
007      
ta
008      
131021s2008 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.931495 $2 doi
035    __
$a (PubMed)18271686
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Orlická, Eliška $u Institute of Endocrinology, Prague, Czech Republic $7 _AN075208
245    10
$a TRH test in patients with diabetes mellitus type 1 and/or autoimmune thyroiditis. Changes in the pituitary-thyroid axis, reverse T3, prolactin and growth hormone levels / $c E. Orlická, K. Vondra, M. Hill, J. Skibová, I. Sterzl, V. Zamrazil
520    9_
$a The response of the pituitary- thyroid axis, reverse triiodothyronine (rT3), prolactin, and growth hormone (GH) levels following TRH stimulus (Relefact TRH 200 microg 2 amp. i.v.) was examined in patients with autoimmune diabetes type 1 (DM1, n=30), with autoimmune thyroiditis (AT, n=25), and with concurrent DM1 and AT (n=22) to evaluate the influence of DM1 and AT of autoimmune pathogenesis on the above-mentioned hormonal parameters. Statistical analysis (ANOVA) showed that: a) the response of TSH did not differ from control groups (C); b) free triiodothyronine (fT3), free thyroxine (fT4) and their ratio in DM1, DM1+AT and C rose in 120 and 180 min, while a similar increase was not seen in AT (p<0.000001); c) rT3 was not present in any group, with rT3 levels higher in AT (p<0.00002) and lower in DM1 (p<0.02); d) the response of GH had a paradoxical character in some patients in all groups, most often in DM1 (52 %, DM1 vs C, p <0.01). The characteristic response difference was not in the peak GH level, but the delayed return to basal levels in DM1 (p<0.0001) and an abrupt one in AT (p<0.0001). The major findings in DM1 were the differences in GH response, while significant impairment of pituitary-thyroid axis and PRL response to TRH was absent. AT was associated with impairment of TRH stimulated fT3, fT4, fT3/fT4 response and changes in rT3 levels, in spite of preserved TRH-stimulated TSH secretion. GH response in AT patients was also altered.
650    _2
$a dospělí $7 D000328
650    _2
$a diabetes mellitus 1. typu $x diagnóza $x metabolismus $7 D003922
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a hormony $x krev $7 D006728
650    _2
$a lidský růstový hormon $x krev $7 D019382
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a hypofýza $x metabolismus $7 D010902
650    _2
$a prolaktin $x krev $7 D011388
650    _2
$a štítná žláza $x metabolismus $7 D013961
650    _2
$a autoimunitní tyreoiditida $x diagnóza $x metabolismus $7 D013967
650    _2
$a hormon uvolňující thyreotropin $x diagnostické užití $7 D013973
650    _2
$a thyroxin $x krev $7 D013974
650    _2
$a trijodthyronin $x krev $7 D014284
650    _2
$a trijodthyronin reverzní $x krev $7 D014285
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Vondra, Karel, $u Institute of Endocrinology, Prague, Czech Republic $d 1943- $7 jo20000074105
700    1_
$a Hill, Martin, $u Institute of Endocrinology, Prague, Czech Republic $d 1962- $7 mzk2005304431
700    1_
$a Skibová, Jelena $u Institute of Clinical and Experimental Medicine, Prague, Czech Republic $7 xx0061183
700    1_
$a Šterzl, Ivan, $u Institute of Immunology and Microbiology of the First Faculty of Medicine and General Teaching Hospital, Prague; Institute of Endocrinology, Prague, Czech Republic $d 1954- $7 jn20000402887
700    1_
$a Zamrazil, Václav, $u Institute of Endocrinology, Prague, Czech Republic $d 1936-2018 $7 jn20000402707
773    0_
$w MED00003824 $t Physiological research $x 0862-8408 $g Roč. 57,Suppl 1 (2008), s. S109-S117
773    0_
$t From clinical to molecular endocrinology $x 0862-8408 $g Roč. 57,Suppl 1 (2008), s. S109-S117 $w MED00170142
856    41
$u http://www.biomed.cas.cz/physiolres/archive.htm $y domovská stránka časopisu - plný text volně přístupný = fulltext
910    __
$a ABA008 $b A 4120 $c 266 $y 3 $z 0
990    __
$a 20131021 $b ABA008
991    __
$a 20151006120637 $b ABA008
999    __
$a ok $b bmc $g 998517 $s 832587
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2008 $b 57 $c Suppl 1 $d S109-S117 $i 0862-8408 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
BMC    __
$a 2008 $b 57 $c Suppl 1 $d S109-S117 $i 0862-8408 $m From clinical to molecular endocrinology $n $x MED00170142
LZP    __
$b NLK138 $a Pubmed-20131021

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...